Department of Neurobiology & Anatomy, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA 19129, USA.
Exp Neurol. 2012 Feb;233(2):717-32. doi: 10.1016/j.expneurol.2011.11.002. Epub 2011 Nov 10.
Although astrocytes are involved in the production of an inhibitory glial scar following injury, they are also capable of providing neuroprotection and supporting axonal growth. There is growing appreciation for a diverse and dynamic population of astrocytes, specified by a variety of glial precursors, whose function is regulated regionally and temporally. Consequently, the therapeutic application of glial precursors and astrocytes by effective transplantation protocols requires a better understanding of their phenotypic and functional properties and effective protocols for their preparation. We present a systematic analysis of astrocyte differentiation using multiple preparations of glial-restricted precursors (GRP), evaluating their morphological and phenotypic properties following treatment with fetal bovine serum (FBS), bone morphogenetic protein 4 (BMP-4), or ciliary neurotrophic factor (CNTF) in comparison to controls treated with basic fibroblast growth factor (bFGF), which maintains undifferentiated GRP. We found that treatments with FBS or BMP-4 generated similar profiles of highly differentiated astrocytes that were A2B5-/GFAP+. Treatment with FBS generated the most mature astrocytes, with a distinct and near-homogeneous morphology of fibroblast-like flat cells, whereas BMP-4 derived astrocytes had a stellate, but heterogeneous morphology. Treatment with CNTF induced differentiation of GRP to an intermediate state of GFAP+cells that maintained immature markers and had relatively long processes. Furthermore, astrocytes generated by BMP-4 or CNTF showed considerable experimental plasticity, and their morphology and phenotypes could be reversed with complementary treatments along a wide range of mature-immature states. Importantly, when GRP or GRP treated with BMP-4 or CNTF were transplanted acutely into a dorsal column lesion of the spinal cord, cells from all 3 groups survived and generated permissive astrocytes that supported axon growth and regeneration of host sensory axons into, but not out of the lesion. Our study underscores the dynamic nature of astrocytes prepared from GRP and their permissive properties, and suggest that future therapeutic applications in restoring connectivity following CNS injury are likely to require a combination of treatments.
尽管星形胶质细胞参与了损伤后抑制性神经胶质瘢痕的形成,但它们也能够提供神经保护和支持轴突生长。人们越来越认识到星形胶质细胞是一种多样化和动态的细胞群体,由多种神经胶质前体细胞组成,其功能在区域和时间上受到调节。因此,通过有效的移植方案应用神经胶质前体细胞和星形胶质细胞进行治疗,需要更好地了解它们的表型和功能特性,以及它们的有效制备方案。我们使用多种神经胶质限制定殖前体细胞 (GRP) 制剂,对星形胶质细胞分化进行了系统分析,评估了它们在胎牛血清 (FBS)、骨形态发生蛋白 4 (BMP-4) 或睫状神经营养因子 (CNTF) 处理后的形态和表型特性,并与用碱性成纤维细胞生长因子 (bFGF) 处理的对照物进行了比较,bFGF 维持未分化的 GRP。我们发现,用 FBS 或 BMP-4 处理会生成类似的高度分化星形胶质细胞图谱,这些细胞为 A2B5-/GFAP+。用 FBS 生成的星形胶质细胞最成熟,具有明显且近乎同质的成纤维样扁平细胞形态,而 BMP-4 衍生的星形胶质细胞具有星状但异质的形态。用 CNTF 处理可诱导 GRP 分化为具有不成熟标志物的中间状态的 GFAP+细胞,并具有相对较长的突起。此外,用 BMP-4 或 CNTF 生成的星形胶质细胞表现出相当大的实验可塑性,其形态和表型可以通过互补处理在广泛的成熟-不成熟状态之间逆转。重要的是,当 GRP 或用 BMP-4 或 CNTF 处理的 GRP 被急性移植到脊髓背柱损伤部位时,来自所有 3 个组的细胞均存活下来,并生成了允许轴突生长和宿主感觉轴突再生的允许性星形胶质细胞,但轴突不能从损伤中再生。我们的研究强调了从 GRP 制备的星形胶质细胞的动态特性及其允许性特性,并表明在中枢神经系统损伤后恢复连接的未来治疗应用可能需要组合治疗。